BRCA cascade counselling and testing in Italy: current position and future directions
Silvia Costanzo1, Lea Godino2, Simona De Summa3
1Heredo-Familiar Cancer Clinic, IRCCS - Istituto Tumori''Giovanni Paolo II'', Bari, Italy. s.costanzo@oncologico.bari.it.
BMC Cancer
|July 2, 2025
Summary
Genetic testing for Hereditary Breast and Ovarian Cancer syndrome identifies at-risk individuals. Traditional Genetic Counseling (TGC) improves understanding of genetic risks and prevention strategies more than Mainstream Cancer Genetics (MCG).
Area of Science:
- Genetics
- Oncology
- Public Health
Background:
- Genetic testing for BRCA1/2 variants aids in identifying hereditary breast and ovarian cancer (HBOC) risk.
- Barriers in intrafamilial communication and privacy regulations impede preventive care for HBOC.
- Italian legal constraints limit the disclosure of genetic risks to at-risk relatives.
Purpose of the Study:
- To examine the relationship between BRCA1/2 carriers' communication challenges and cancer status.
- To assess the impact of genetic information comprehension on communication.
- To compare communication challenges based on the genetic counseling pathway (TGC vs. MCG).
Main Methods:
- A multicenter, prospective, observational study of 277 BRCA1/2 carriers (probands and relatives).
- Participants completed sociodemographic forms, surveys, and psychological assessments (IES, DT).
- Statistical analysis included Chi-squared/Fisher's exact tests and Wilcoxon rank-sum test.
Main Results:
- Cancer prevalence was higher in probands (83%) than relatives (22%).
- Psychological distress was associated with cancer diagnosis rather than genetic status.
- Genetic comprehension was significantly higher in relatives and those receiving TGC compared to MCG.
Conclusions:
- Psychological distress and genetic comprehension significantly influence communication regarding hereditary cancer risks.
- Traditional Genetic Counseling (TGC) enhances understanding of genetic risks and management more effectively than Mainstream Cancer Genetics (MCG).
- Tailored support is needed for carriers and healthcare professionals to improve cascade counseling, testing, and cancer prevention.
Related Concept Videos
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.7K


